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ABSTRAK
Intravascular papillary endothelial hyperplasia (IPEH) atau Masson’s tumor 
merupakan sejenis proliferasi vaskular yang berkelakuan lebih kurang sama dengan 
tumor vaskular malignan yang lain. Sehingga kini, laporan kes ini merupakan kes 
tumor Masson uretra yang keempat yang pernah dilaporkan. Seorang wanita yang 
berusia 65, para 2 datang dengan pendarahan dari vagina selepas menopos. Satu 
ketumbuhan bersaiz 4x3x3 cm dijumpai di uretra meatus sewaktu pemeriksaan 
fizikal. Pesakit telah menjalani pemeriksaan di bawah bius dan ketumbuhan 
tersebut telah dibedah siasat. Tumor Masson telah dikenalpasti melalui pemeriksaan 
histopatologi. Diagnosis dan pengendalian kes luar biasa ini akan dibincang dalam 
laporan kes ini.
Kata kunci: angiosarcoma, hiperplasia endothelia, tumor Masson, ketumbuhan uretra, 
ketumbuhan vaskular
ABSTRACT
Intravascular papillary endothelial hyperplasia (IPEH) or Masson’s tumour is a 
benign vascular proliferation that mimics other malignant vascular tumour. To 
date, this is the fourth case of Masson’s tumour at urethra being reported in the 
literature. A 65-year-old female Para 2, presented with post-menopausal bleeding. 
Examination revealed a 4x3x3 cm growth surrounding the urethral meatus. She 
underwent examination under anaesthesia and excision of the periurethral mass. 
Histopathological examination confirmed Masson’s tumour. Diagnosis and 
management of this uncommon tumour at a rare location was discussed. 
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urethral meatus. Punch biopsy was 
taken and sent for histo-pathological 
examination (HPE). 
 HPE of the biopsy showed few 
segments of brownish tissue with 
aggregate diameter of 18 mm, 
macroscopically. Microscopically, there 
were few segments of haemorrhagic 
and oedematous fibrous stromal tissue. 
The stroma was hypocellular and 
oedematous, composed of multiple 
thombosed vessels with some of 
them displayed intravascular papillary 
endothelial cells proliferation (Figure 1). 
The endothelial cells expressed CD34 
(Figure 2). There was no dysplasia or 
evidence of malignancy. The HPE was 
consistent with intravascular papillary 
epithelial cell proliferation (Masson’s 
tumour). She subsequently underwent 
examination under anaesthesia and full 
excision of the remaining lesion (Figure 
3).
Keywords: angiosarcoma, endothelial hyperplasia, Masson’s tumour, urethral 
neoplasm, vascular neoplasm
INTRODUCTION
Intravascular papillary endothelial 
hyperplasia (IPEH) is a unique clinical 
entity i.e. a non-neoplastic intravascular 
lesion. This lesion was first described 
by Pierre Masson in 1923 (Masson 
1923) then was termed IPEH (Clearkin 
& Enzinger 1976). So far, various 
researchers have struggled to define 
this unique condition with various 
terminologies such as Masson’s tumour, 
vegetating hemangioendothelioma, 
intravascular angiomatosis etc. This 
lesion should be differentiated from 
other malignant vascular neoplasm like 
angiosarcoma. We report an extremely 
rare case of IPEH that occurred in 
female urethra. 
CASE REPORT
A 65-year-old Para 2, post-menopausal 
for 10 yrs not on hormone replacement 
therapy, presented with vaginal 
bleeding for one-week duration. There 
was no abnormal vaginal discharge or 
urinary symptoms. Her last Pap smear 
was 10 yrs ago. She was diagnosed to 
have hypertension and dyslipidaemia 
on treatment. Her aunt suffered from 
breast carcinoma. 
 Upon presentation, her blood 
pressure was 126/64mm Hg with pulse 
rate of 86 beats/min. There was no 
mass palpable abdominally. Perineal 
inspection revealed an atrophic vulva 
and vagina. There was a 3.0 x 3.0 x 
4.0 cm growth seen surrounding the 
Figure 1: The lesion composed of a polypoidal 
mass that was lined by a hyperplastic 
urothelium, with rounded nests of urothelium 
forming glandular spaces in the stroma. The 
stroma contained many small blood vessels.
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DISCUSSION
To date, the pathogenesis of IPEH 
remained poorly understood. Possible 
mechanisms include papillary 
proliferation of endothelial cell that 
subsequently degenerates and necrosis 
in the vascular lumen. Hashimoto et 
al. (1983) classified IPEH into 3 types. 
Type I IPEH (primary or pure form) 
occurs within the vascular spaces, 
where as, Type II is mixed form that 
occurs at pre-existing vascular lesion 
such as haemangioma, arteriovenous 
malformation or pyogenic granuloma. 
Lastly, Type III, the least common type, 
is found in extravascular space. All 
these lesions were closely associated 
with thrombus and thrombotic material 
(Pegado et al. 2015).
 Most IPEH developed in head and 
neck, extremities and trunk (Hashimoto 
et al. 1983). It was rarely found in 
the genitourinary area especially 
urethra. Clinically, IPEH elsewhere 
usually presented as a firm tender 
mass overlying the skin or mucous 
membrane where as urethral IPEH 
presented with vaginal bleeding. To 
date, there are only four reports of 
urethral IPEH (Nevin et al. 2006; Barua 
& Munday 1983; Fernandes-Flores et 
al. 2003)  (Table 1). All reported cases 
were post-menopausal women who 
were above 60 yrs. 
 Due to its non-specific clinical 
presentation; it poses a significant 
diagnostic challenge as malignant 
vascular neoplasm like angiosarcoma 
needs to be ruled out especially in 
elderly patient. Histopathologically, 
IPEH is associated with thrombi in an 
expanded vessel without evidence of 
mitotic activity, atypia or necrosis. The 
cells do not invade the perivascular 
spaces compared to angiosacrcoma. 
Immunochemically, IPEH reacts with 
various substances such as MSA, 
SMA, CD31 and CD34. Fortunately, 
angiosacrcoma can be differentiated 
with CD 105 staining as this molecule 
only overexpressed in angiosarcoma 
associated endothelial cells (Soares et 
al. 2008; Akdur et al. 2013).
 The prognosis of IPEH is very good. 
Treatment includes local excision. 
Recurrence is extremely rare, though, 
it might occur at the site of previous 
vascular lesion or if the lesion is 
Figure 2: The endothelial cells expressed CD34
Figure 3: An oedematous polypoidal growth at 
the urethral meatus
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incompletely excised (Inaioz et al. 
2001). The present patient presented 
with post-menopausal bleeding 
secondary to urethral IPEH. There was 
no evidence of recurrence after one 
year of excision. 
 IPEH at female urethra is an extremely 
rare occurrence. The lesion must be 
differentiated from other malignant 
vascular neoplasm. Surgical excision 
is warranted for histopathological 
examination as incorrect diagnosis may 
lead to over aggressive treatment.   
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Table 1: Summaries of IPEH infemale urethral 
Case Age Post menopause Presentation Physical finding Size (cm)
Nevin et al 2006 67 Yes Vaginal bleeding exophytic urethral mass 2.0 x 0.4 x 0.7
Barua and Munday 
1983 60 Yes- 12 years
Vaginal 
bleeding
irregular black mass 
from anterior lip of 
urethral meatus
3.5 x 3.0 x 3.0
Fernandez et al 
2003 72 -
Vaginal 
bleeding mass in urethral meatus 1.0 x 1.0 x 0.5
Current case 65 Yes-10 years Vaginal bleeding mass in urethral meatus 3.0 x 3.0 x 4.0
